GET THE APP

Stability indicating method development and validation for the estimation of aprepitant by RP-HPLC in bulk and pharmaceutical dosage form | Abstract
Scholars Research Library

Scholars Research Library

A-Z Journals

+44 7389645282

Der Pharmacia Lettre

Abstract

Stability indicating method development and validation for the estimation of aprepitant by RP-HPLC in bulk and pharmaceutical dosage form

Author(s): P. Geetha Swarupa, D. Radha Krishna, K. R. S. Prasad1 and K. Suresh Babu

The purpose of the investigation was to develop a new RP-HPLC Method for estimation of Aprepitant in pharmaceutical dosage forms. Chromatography was carried out on an Kromosil C18 column (4.6 x 250mm, 5μ particle size) with a isocratic mobile phase composed of 0.1% Perchloric acid, Acetonitrile (80:20v/v) at a flow rate of 1.1 mL/min. The column temperature was maintained at 30°C and the detection was carried out using a PDA detector at 210 nm. Validation parameters such as system suitability, linearity, precision, accuracy, specificity, limit of detection (LOD), limit of quantification (LOQ), Stability of sample and standard stock solutions and robustness were studied as reported in the International Conference on Harmonization guidelines. The retention time for Aprepitant was 3.429 min. The percentage recovery of Aprepitant was 101.01%. The relative standard deviation for assay of capsule was found to be less than 2%. The Method was fast, accurate, precise and sensitive hence it can be employed for routine quality control of capsules containing drugs in quality control laboratories and pharmaceutical industries.